After a promising start, biotech IPOs all but fizzled out this year, but LB Pharmaceuticals is hoping that won't stymy its chances of completing a Nasdaq listing. New York-based LB is hoping to raise ...

Python and Jupyter offer a simple, powerful setup for beginner-friendly data science learning. Real-world datasets make each project practical and industry-relevant. Skills gained cover analysis, ...

Send a note to Doug Wintemute, Kara Coleman Fields and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...

“1000-lb Sisters” fans have been watching Tammy and Amy Slaton’s journey for years, but is the TLC reality series coming to an end? The “1000-lb Sisters” season 7 finale aired in June, and season 8 ...

LB Pharmaceuticals and Celldex have separately stepped up their respective launch preparations by appointing new chief commercial officers, according to a pair of announcements this week. New ...

“1000-lb Sisters” star Tammy Slaton continues to wow fans with her weight loss transformation. Amy, for her part, lost nearly 200 pounds after undergoing bariatric surgery in 2019. She looked dazzling ...

Picture yourself sorting laundry, calmly separating whites from darks—when suddenly you come face-to-face with something massive and scaly. That’s exactly what happened to one Australian woman, who ...

LB Pharmaceuticals aims to show that what is old can become new again with a lead drug candidate that’s a modified version of a decades-old schizophrenia medication from Sanofi. The strategy is ...

LB Pharmaceuticals’ decision to break cover and go public seems to have paid off, with the company bumping up the number of shares on offer for its Nasdaq listing this morning. The CNS-focused biotech ...

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals”) today announced the pricing of its upsized initial public offering of 19,000,000 shares of its common stock ...

Sept 10 (Reuters) - LB Pharmaceuticals raised $285 million in its U.S. initial public offering, the biotech firm said on Wednesday, marking the first sizable biotech IPO since February. The New ...